Schedule 13D ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2018-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-057895
- Form type
- SC 13D
- Filer
- Novo Holdings A/S
- CIK
- CIK 1388325
- Filed
- Feb 26, 2018
- Reporting period
- Feb 16, 2018
- Description
- Schedule 13D beneficial ownership